FBDIX vs. FBGRX
Compare and contrast key facts about Franklin Biotechnology Discovery Fund (FBDIX) and Fidelity Blue Chip Growth Fund (FBGRX).
FBDIX is managed by Franklin Templeton. It was launched on Sep 14, 1997. FBGRX is managed by Fidelity. It was launched on Dec 31, 1987.
Performance
FBDIX vs. FBGRX - Performance Comparison
Loading graphics...
FBDIX vs. FBGRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBDIX Franklin Biotechnology Discovery Fund | 2.34% | 52.68% | 15.37% | 18.40% | -12.65% | -27.58% | 29.85% | 49.11% | -15.77% | 18.83% |
FBGRX Fidelity Blue Chip Growth Fund | -7.12% | 19.91% | 39.77% | 55.61% | -38.45% | 22.64% | 62.20% | 33.43% | 1.02% | 36.01% |
Returns By Period
In the year-to-date period, FBDIX achieves a 2.34% return, which is significantly higher than FBGRX's -7.12% return. Over the past 10 years, FBDIX has underperformed FBGRX with an annualized return of 10.84%, while FBGRX has yielded a comparatively higher 19.08% annualized return.
FBDIX
- 1D
- 5.83%
- 1M
- -0.40%
- YTD
- 2.34%
- 6M
- 25.15%
- 1Y
- 69.79%
- 3Y*
- 28.39%
- 5Y*
- 7.17%
- 10Y*
- 10.84%
FBGRX
- 1D
- 4.54%
- 1M
- -5.07%
- YTD
- -7.12%
- 6M
- -4.04%
- 1Y
- 26.78%
- 3Y*
- 26.54%
- 5Y*
- 11.74%
- 10Y*
- 19.08%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBDIX vs. FBGRX - Expense Ratio Comparison
FBDIX has a 1.06% expense ratio, which is higher than FBGRX's 0.79% expense ratio.
Return for Risk
FBDIX vs. FBGRX — Risk / Return Rank
FBDIX
FBGRX
FBDIX vs. FBGRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Biotechnology Discovery Fund (FBDIX) and Fidelity Blue Chip Growth Fund (FBGRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBDIX | FBGRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.47 | 1.13 | +1.34 |
Sortino ratioReturn per unit of downside risk | 3.14 | 1.73 | +1.41 |
Omega ratioGain probability vs. loss probability | 1.40 | 1.25 | +0.16 |
Calmar ratioReturn relative to maximum drawdown | 4.35 | 2.00 | +2.35 |
Martin ratioReturn relative to average drawdown | 17.17 | 7.92 | +9.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBDIX | FBGRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.47 | 1.13 | +1.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.47 | -0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.41 | 0.81 | -0.40 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.41 | 0.65 | -0.24 |
Correlation
The correlation between FBDIX and FBGRX is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FBDIX vs. FBGRX - Dividend Comparison
FBDIX's dividend yield for the trailing twelve months is around 10.56%, more than FBGRX's 2.05% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBDIX Franklin Biotechnology Discovery Fund | 10.56% | 10.81% | 19.53% | 0.00% | 0.13% | 0.98% | 14.50% | 18.77% | 3.72% | 2.39% | 4.57% | 8.42% |
FBGRX Fidelity Blue Chip Growth Fund | 2.05% | 1.90% | 5.95% | 0.93% | 0.57% | 8.73% | 6.40% | 3.70% | 6.32% | 4.23% | 4.05% | 5.30% |
Drawdowns
FBDIX vs. FBGRX - Drawdown Comparison
The maximum FBDIX drawdown since its inception was -71.44%, which is greater than FBGRX's maximum drawdown of -58.64%. Use the drawdown chart below to compare losses from any high point for FBDIX and FBGRX.
Loading graphics...
Drawdown Indicators
| FBDIX | FBGRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.44% | -58.64% | -12.80% |
Max Drawdown (1Y)Largest decline over 1 year | -12.39% | -13.89% | +1.50% |
Max Drawdown (5Y)Largest decline over 5 years | -46.83% | -43.08% | -3.75% |
Max Drawdown (10Y)Largest decline over 10 years | -53.67% | -43.08% | -10.59% |
Current DrawdownCurrent decline from peak | -1.98% | -8.68% | +6.70% |
Average DrawdownAverage peak-to-trough decline | -28.90% | -12.58% | -16.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.44% | 3.51% | -0.07% |
Volatility
FBDIX vs. FBGRX - Volatility Comparison
Franklin Biotechnology Discovery Fund (FBDIX) has a higher volatility of 9.67% compared to Fidelity Blue Chip Growth Fund (FBGRX) at 7.83%. This indicates that FBDIX's price experiences larger fluctuations and is considered to be riskier than FBGRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBDIX | FBGRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.67% | 7.83% | +1.84% |
Volatility (6M)Calculated over the trailing 6-month period | 16.55% | 14.08% | +2.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.07% | 24.98% | +1.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.57% | 24.93% | +0.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.40% | 23.63% | +2.77% |